- Home
- CELH vs SNN Comparison
CELH vs SNN Comparison
Compare CELH & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELH
- SNN
- Stock Information
- Founded
- CELH 2004
- SNN 1856
- Country
- CELH United States
- SNN United Kingdom
- Employees
- CELH N/A
- SNN N/A
- Industry
- CELH Beverages (Production/Distribution)
- SNN Industrial Specialties
- Sector
- CELH Consumer Staples
- SNN Health Care
- Exchange
- CELH Nasdaq
- SNN Nasdaq
- Market Cap
- CELH 15.3B
- SNN 15.2B
- IPO Year
- CELH N/A
- SNN 1999
- Fundamental
- Price
- CELH $45.48
- SNN $33.55
- Analyst Decision
- CELH Strong Buy
- SNN Hold
- Analyst Count
- CELH 18
- SNN 4
- Target Price
- CELH $62.39
- SNN $32.83
- AVG Volume (30 Days)
- CELH 7.4M
- SNN 588.2K
- Earning Date
- CELH 11-06-2025
- SNN 10-30-2025
- Dividend Yield
- CELH N/A
- SNN 2.18%
- EPS Growth
- CELH N/A
- SNN 59.91
- EPS
- CELH 0.13
- SNN 0.56
- Revenue
- CELH $2,125,838,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- CELH $85.38
- SNN $7.85
- Revenue Next Year
- CELH $31.08
- SNN $5.43
- P/E Ratio
- CELH $357.30
- SNN $60.06
- Revenue Growth
- CELH 55.07
- SNN 5.35
- 52 Week Low
- CELH $21.10
- SNN $23.69
- 52 Week High
- CELH $66.74
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- CELH 30.38
- SNN 36.87
- Support Level
- CELH $43.17
- SNN $33.05
- Resistance Level
- CELH $61.49
- SNN $33.60
- Average True Range (ATR)
- CELH 2.65
- SNN 0.50
- MACD
- CELH -2.14
- SNN -0.35
- Stochastic Oscillator
- CELH 20.83
- SNN 33.30
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. The firm now owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy. It dedicates its efforts to product innovation and marketing while outsourcing manufacturing and packaging to third-party co-packers and distribution to PepsiCo. The firm issued convertible preferred shares following PepsiCo's investments in 2022 and 2025, giving the latter an 11% stake in Celsius.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.